Latest Burford Quarterly explores key trends driving innovation in commercial disputes in 2025

Rhea-AI Summary

Burford Capital has released its first Quarterly journal of 2025, focusing on innovative financial strategies in commercial disputes. The publication explores how businesses and law firms are transforming their approach to legal finance, including alternative billing structures and IP asset monetization.

The Quarterly features articles on legal finance innovation for law firms, healthcare antitrust opt-outs with focus on the upcoming March 2025 Blue Cross Blue Shield antitrust class actions deadline, IP potential in life sciences, and perspectives on international arbitration in London. The articles discuss how legal finance helps firms solve challenges, accelerate growth, and mitigate financial strain in high-cost litigation.

According to Aviva Will, President of Burford Capital, legal finance serves as a catalyst for innovation in the legal industry by providing capital, mitigating risk, and removing barriers for business growth.

Positive

• Publication demonstrates Burford's thought leadership in legal finance industry
• Strategic focus on high-value sectors including healthcare and life sciences
• Expansion of services into IP asset monetization and healthcare litigation funding

Negative

• None.

Insights

Market Research Analyst

The latest Burford Quarterly publication represents a standard marketing initiative to showcase the company's thought leadership, without containing material financial information or business updates that would impact stock valuation. While the publication discusses important industry trends like healthcare antitrust opt-outs and IP monetization in life sciences, these are educational pieces rather than announcements of new business developments or financial performance.

The content appears designed to reinforce Burford's market position and educate potential clients about litigation funding opportunities, but does not disclose any new deals, financial metrics, or material changes to business strategy. From an investor perspective, this type of regular industry publication serves primarily as a marketing and brand-building tool rather than market-moving news.

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Burford Capital, the leading global finance and asset management firm focused on law, today releases its latest Burford Quarterly, a journal of legal finance that explores top trends at the nexus of law and finance.

This Burford Quarterly examines the innovative ways in which businesses and law firms are reimagining their financial strategies around commercial disputes. Examples of this include law firms using creative billing structures as alternatives to hourly fees; companies choosing to opt out of litigation to maximize and accelerate recoveries; or businesses monetizing IP assets, allowing for continued investment in other vital areas of the business.

Articles in the Burford Quarterly No.1 2025 include:

• The innovation engine: Legal finance for forward-thinking law firms
  As law firms launch into 2025, a year that promises continued disruption and opportunity, innovation is not a choice—it's an imperative. Forward-thinking firms are reimagining their financial strategies, moving beyond traditional models to embrace legal finance as a critical tool for transformation. In this article, Travis Lenkner and Emily Slater explore innovative ways legal finance is helping firms solve pressing challenges and accelerate growth. 

• Healthcare antitrust opt-outs: Improving liquidity by monetizing valuable legal claims
  An increasing number of healthcare businesses are recognizing the value that legal finance provides in helping to mitigate the financial strain of high-cost litigation and expedite recoveries in high-stakes litigation. Ahead of a March 2025 opt-out deadline for claimants in the Blue Cross Blue Shield (BCBS) antitrust class actions, Charles Griffin summarizes insights from a recent webcast in which experts from Burford and Paul Hastings presented factors hospital networks and providers should consider in weighing their options.

• Legal finance and life sciences: Unlocking IP potential in pharma, biotech and medical devices
  Innovation in Europe's life sciences and pharmaceutical sectors is vital, but long R&D cycles and short profit windows pose challenges. Joshua Harris explains how legal finance helps companies protect and monetize IP assets, enabling continued investment in life-saving technologies.

• International arbitration in London: Next-Gen leaders' perspective
  Geoff Nicholas, Christiane Deniger and James MacKinnon lead a Burford roundtable with London-based arbitration lawyers. Partners from A&O Shearman, Debevoise & Plimpton, Bryan Cave Leighton Paisner and Freshfields share their insights on key trends and challenges shaping international arbitration, including the use of technology and AI and arbitral efficiency.

Aviva Will, President of Burford Capital, says: "While the legal industry may be slow to evolve, legal finance is a powerful tool to drive innovation in the business of law. This issue of the Burford Quarterly highlights key trends in commercial litigation and arbitration in 2025 and shows how litigation funding continues to shape the legal industry. By providing capital and mitigating risk, funding removes barriers for businesses and facilitates growth, and the latest Quarterly brings insights, analysis and real-world examples of tools to help business executives, GCs, CLOs and law firm attorneys recognize and harness the full potential of finance for law."

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its offices in New York, London, Chicago, Washington, DC, Singapore, Dubai and Hong Kong.

For more information, please visit www.burfordcapital.com.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

View original content to download multimedia:https://www.prnewswire.com/news-releases/latest-burford-quarterly-explores-key-trends-driving-innovation-in-commercial-disputes-in-2025-302353384.html

SOURCE Burford Capital

FAQ

What key trends does Burford Capital (BUR) identify for legal finance in 2025?

Burford Capital identifies alternative billing structures, litigation opt-outs for maximizing recoveries, and IP asset monetization as key trends in legal finance for 2025.

What is the significance of the March 2025 deadline mentioned in Burford's (BUR) Quarterly?

March 2025 marks the opt-out deadline for claimants in the Blue Cross Blue Shield antitrust class actions, which represents a significant opportunity for healthcare businesses to utilize legal finance.

How is Burford Capital (BUR) addressing innovation in the life sciences sector?

Burford is helping life sciences companies protect and monetize IP assets to enable continued investment in R&D, addressing challenges of long development cycles and short profit windows.

What solutions does Burford Capital (BUR) offer for law firms in 2025?

Burford offers legal finance solutions to help law firms transform their financial strategies, solve pressing challenges, and accelerate growth beyond traditional models.